• Home
  • »
  • News
  • »
  • Cochrane Colloquium Edinburgh 2018

Cochrane Colloquium Edinburgh 2018

Tuesday, 23 Jan 2018

 

The opportunity to present workshops, special sessions, oral presentations and posters opens on 5 January 2018. This is your chance to be part of the 25th annual Cochrane Colloquium. The theme of the event is ‘Cochrane for all – better evidence for better health decisions’ and we look forward to receiving submissions on the sub-themes of ‘producing evidence’, ‘making evidence accessible’ and ‘advocating for evidence’.

The 2018 Colloquium will be held in Edinburgh at the International Conference Centre in Scotland from 16-18 September 2018. It will hosted by Cochrane UK and is expected to attract up to 1200 delegates.

The Colloquium will be a Patients Included event. One of the key aims of the event is to increase the involvement of patients, carers and family members (healthcare consumers) in Cochrane’s work. As such, we ask that all abstracts consider their impact on, and relevance to, patients and other healthcare consumers. We particularly welcome abstracts that are co-designed, co-produced and/or co-presented with patients or other healthcare consumers.

View the call for abstracts

View the call for workshops 

The deadline for submissions is 2 March 2018.

 

The CIDG editorial base is located at the Liverpool School of Tropical Medicine in Liverpool, UK. The CIDG is led by Professor Paul Garner (Co-ordinating Editor) and Deirdre Walshe (Managing Editor). Over 600 authors from some 52 countries contribute to the preparation of the Cochrane Reviews. They are supported by an international team of Editors, each with topic or methodological expertise. 

The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment infectious diseases of relevance to the United Nations Sustainable Development Goals, particularly malaria, tuberculosis, HIV/AIDS, and neglected tropical diseases. The aims of the CIDG are to impact on policy and research in tropical diseases through the production of high quality and relevant systematic reviews, and to lead developments in review quality improvement and effective dissemination of findings.